SynthesisCancer medicine2023

The efficacy and safety of immune checkpoint inhibitors for patients with EGFR-mutated non-small cell lung cancer who progressed on EGFR tyrosine-kinase inhibitor therapy: A systematic review and network meta-analysis.

Zhen Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.